Exogenous Expression of Fas-Ligand or CrmA Prolongs the Survival in Rat Liver Transplantation

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2710-2713

  Adachi, K ^a,b   Fujino, M ^a,c   Kitazawa, Y ^a   Funeshima Fuji, N ^a   Takahara, S ^d   Kimura, H ^a   Li, X K ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; CYTOKINE RESPONSE MODIFIER A; EOSIN; FAS LIGAND;

ADENOVIRUS VECTOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION SYSTEM; GENETIC TRANSFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; LACTOSE OPERON; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MALE; NICK END LABELING; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANK SUM TEST; RAT; SPECIES COMPARISON; STATISTICAL ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINATION;

ANIMALS; BETA-GALACTOSIDASE; FAS LIGAND PROTEIN; GENETIC VECTORS; GRAFT REJECTION; GRAFT SURVIVAL; LIVER TRANSPLANTATION; MODELS, ANIMAL; RATS; RATS, INBRED LEW; SERPINS; TRANSFECTION; TRANSPLANTATION, HOMOLOGOUS; VIRAL PROTEINS;

EID: 33750626231     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.011     Document Type: Article

References (26)

1. Kaizu T., Ikeda A., and Nakao A. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival. Hepatology 43 (2006) 464
2. Rentsch M., Kienle K., and Mueller T. Adenoviral bcl-2 transfer improves survival and early graft function after ischemia and reperfusion in rat liver transplantation. Transplantation 80 (2005) 1461
3. Ke B., Buelow R., and Shen X.D. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 13 (2002) 1189
4. Ray C.A., Black R.A., and Kronheim S.R. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69 (1992) 597
5. Zhou Q., Snipas S., and Orth K. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J Biol Chem 272 (1997) 7797
6. Quan L.T., Caputo A., and Bleackley R.C. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J Biol Chem 270 (1995) 10377
7. Turner P.C., Sancho M.C., and Thoerines S.R. Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells. J Virol 73 (1999) 6394
8. Hashimoto M., Aruga J., and Hosoya Y. A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum Gene Ther 7 (1996) 149
9. Okuyama T., Fujino M., and Li X.K. Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system. Gene Ther 5 (1998) 1047
10. Kanegae Y., Lee G., and Sato Y. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 23 (1995) 3816
11. Adachi K., Fujino M., and Kitazawa Y. Genetic heterogeneity and efficiency of two different methods of adenovirus-mediated gene transfer in a rat liver transplantation model. Surg Today 36 (2006) 367
12. Kamada N., and Calne R.Y. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 93 (1983) 64
13. Fujino M., Li X.K., and Funeshima N. Exogenous gene expression by Cre/IoxP-mediated switching system containing adenovirus vector in mouse. Organ Biology 5 (1998) 45
14. Fujino M., Adachi K., and Kawasaki M. Prolonged survival of rat liver allograft with adenoviral gene transfection of human immunodeficiency virus type 1 nef. Liver Transpl 9 (2003) 805
15. Kabelitz D. Apoptosis, graft rejection, and transplantation tolerance. Transplantation 65 (1998) 869
16. Bellgrau D., Gold D., and Selawry H. A role for CD95 ligand in preventing graft rejection. Nature 377 (1995) 630
17. Griffith T.S., Brunner T., and Fletcher S.M. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189
18. Zhang H.G., Su X., and Liu D. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. J Immunol 162 (1999) 1423
19. George J.F., Sweeney S.D., and Kirklin J.K. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat Med 4 (1998) 333
20. Lau H.T., Yu M., and Fontana A. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273 (1996) 109
21. Kang S.M., Schneider D.B., and Lin Z. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 3 (1997) 738
22. Judge T.A., Desai N.M., and Yang Z. Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival. Transplantation 66 (1998) 426
23. Takeuchi T., Ueki T., and Nishimatsu H. Accelerated rejection of Fas ligand-expressing heart grafts. J Immunol 162 (1999) 518
24. Li X.K., Okuyama T., and Tamura A. Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid. Transplantation 66 (1998) 1416
25. Arai H., Gordon D., and Nabel E.G. Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci USA 94 (1997) 13862
26. Ploegh H.L. Viral strategies of immune evasion. Science 280 (1998) 248